Principal Investigators


Institution


Contact information of lead PI


Country


European Commission

Title of project or programme


Aetionomy: Organising Mechanistic Knowledge about Neurodegenerative Diseases for the Improvement of Drug Development and Therapy

Source of funding information


European Commission FP7-IMI-Seventh Framework Programme/Innovative Medicines Initiative

Total sum awarded (Euro)


€ 7,993,234

Start date of award


01/01/2014

Total duration of award in years


5.0

The project/programme is most relevant to:


Alzheimer's disease & other dementias|Parkinson's disease & PD-related disorders

Keywords


Research Abstract


Today, diseases are defined largely on the basis of their symptoms, yet while two patients may share the same diagnosis, the underlying causes of their symptoms may be very different. This means that a treatment that works in one patient may prove ineffective in another. There is now broad recognition that a new approach to disease classification is needed, and that is where the AETIONOMY project comes in. It will pave the way towards a new approach to the classification of neurodegenerative diseases, particularly Alzheimer’s and Parkinson’s diseases, thereby improving drug development and increasing patients’ chances of receiving a treatment that works for them.

Lay Summary


Further information available at:

Export as PDF